Trial intelligence / Profile preview

Lubiprostone for Constipation in Diabetic Patients

NCT01170039Phase 4Completed

Sponsor
Emory University
Start
Sep 2010
Primary completion
Oct 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in constipation comparing Lubiprostone with Placebo (2 arms). Primary endpoint: Average Number of Spontaneous Bowel Movements (SBMs) Per Week at 8 weeks. Started Sep 2010; status: completed.

02

Drugs

cobiprostone
03

Conditions

constipation

Beyond the preview

Go deeper on NCT01170039.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01170039.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call